Bruce Fireman to Pneumococcal Vaccines
This is a "connection" page, showing publications Bruce Fireman has written about Pneumococcal Vaccines.
Connection Strength
1.381
-
Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults. Vaccine. 2006 Apr 12; 24 Suppl 2:S2-79-80.
Score: 0.256
-
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. 2004 Jun; 23(6):485-9.
Score: 0.225
-
Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003 Jan; 22(1):10-6.
Score: 0.204
-
Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event. Drug Saf. 2020 10; 43(10):1057-1065.
Score: 0.175
-
Lack of association of Kawasaki disease after immunization in a cohort of infants followed for multiple autoimmune diagnoses in a large, phase-4 observational database safety study of 7-valent pneumococcal conjugate vaccine: lack of association between Kawasaki disease and seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2009 May; 28(5):438-40.
Score: 0.079
-
Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007 Sep; 26(9):771-7.
Score: 0.070
-
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J. 2006 Sep; 25(9):779-81.
Score: 0.066
-
Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects. Pediatr Infect Dis J. 2006 Jun; 25(6):494-501.
Score: 0.065
-
Pneumococcal conjugate vaccine in children. N Engl J Med. 2004 Jan 01; 350(1):84-5; author reply 84-5.
Score: 0.055
-
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002 Sep; 21(9):810-5.
Score: 0.050
-
Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2002 May; 21(5):361-5.
Score: 0.049
-
Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J. 2002 Mar; 21(3):182-6.
Score: 0.048
-
Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J. 1999 Sep; 18(9):757-63.
Score: 0.040